# The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome

> **NCT04757493** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 160 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Prucalopride 2mg

## Key facts

- **NCT ID:** NCT04757493
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-10
- **Primary completion:** 2021-10-20
- **Final completion:** 2021-11-20
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04757493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04757493, "The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04757493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*